Latest Stories

Democrats are pressing ahead with spending bills that challenge President Bush to make good on his threat to veto ones that bust his budget. John Dimsdale reports on the likelihood of an ugly confrontation ahead.

New York City's comptroller says the Big Apple would net $142 million during the first three years of legalized gay marriage, mainly from the uptick in visitors attending the nuptials. Ashley Milne-Tyte reports.

Robert Reich says he's all for immigration, but he worries the immigration bill now pending in Congress is going to hurt qualified Americans looking for jobs, not to mention higher salaries.

In Alaska, air taxis are more common than ground taxis. Small planes are integral to the transportation system, carrying everything from commuters to pizza to emergency medical care. But an FAA fuel tax hike could ground many of them, reports Weld Royal.

After enjoying years of unbridled growth, many homebuilders say they're now sinking along with the subprime lending market. So 1,300 of them are in Washington today to ask for help, and they have some unlikely allies, Steve Henn reports.

Congress holds a hearing today on the safety of diabetes drug Avandia. GlaxoSmithKline is mounting an aggressive defense for its No. 2 seller. With sales already plummeting, there's a lot of cash on the line. Helen Palmer reports

The oil-producing countries of OPEC seem to be getting anxious over all this talk about developing biofuels. The cartel says if the U.S. and Europe continue to push in that direction, it could drive oil prices "through the roof."

A potential merger of the two top "natural" foods chains triggers anti-trust concerns, but they argue that traditional supermarkets are offering the same organic options. Ashley Milne-Tyte reports.

Following several domestic and international scandals surrounding the safety of China's food and drug products, the Chinese government has announced a far-reaching plan for improvement. Scott Tong has details.

The diabetes drug Avandia has been linked by a study to heart attacks and deaths. Commentator Dr. Stefan Kertesz says, in addition to the drug itself, the system that led to it being so heavily prescribed should be examined.